Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Worldwide emergence of extensively drug-resistant tuberculosis.
Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. Shah NS, et al. Emerg Infect Dis. 2007 Mar;13(3):380-7. doi: 10.3201/eid1303.061400. Emerg Infect Dis. 2007. PMID: 17552090 Free PMC article.
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.
Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B, Van Deun A, Barrera L, Boulahbal F, Richter E, Martín-Casabona N, Arias F, Zemanova I, Drobniewski F, Santos Silva A, Coulter C, Lumb R, Cegielski JP. Kurbatova EV, et al. Among authors: martin casabona n. Int J Tuberc Lung Dis. 2012;16(3):355-7. doi: 10.5588/ijtld.11.0542. Int J Tuberc Lung Dis. 2012. PMID: 22640449 Free PMC article.
Is second-line anti-tuberculosis drug susceptibility testing reliable?
Kim SJ, Espinal MA, Abe C, Bai GH, Boulahbal F, Fattorin L, Gilpin C, Hoffner S, Kam KM, Martin-Casabona N, Rigouts L, Vincent V. Kim SJ, et al. Int J Tuberc Lung Dis. 2004 Sep;8(9):1157-8. Int J Tuberc Lung Dis. 2004. PMID: 15455606 No abstract available.
Determinants of drug-resistant tuberculosis: analysis of 11 countries.
Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, Smith I, Suarez P, Antunes ML, George AG, Martin-Casabona N, Simelane P, Weyer K, Binkin N, Raviglione MC. Espinal MA, et al. Int J Tuberc Lung Dis. 2001 Oct;5(10):887-93. Int J Tuberc Lung Dis. 2001. PMID: 11605880
Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey.
Martín-Casabona N, Bahrmand AR, Bennedsen J, Thomsen VO, Curcio M, Fauville-Dufaux M, Feldman K, Havelkova M, Katila ML, Köksalan K, Pereira MF, Rodrigues F, Pfyffer GE, Portaels F, Urgell JR, Rüsch-Gerdes S, Tortoli E, Vincent V, Watt B; Spanish Group for Non-Tuberculosis Mycobacteria. Martín-Casabona N, et al. Int J Tuberc Lung Dis. 2004 Oct;8(10):1186-93. Int J Tuberc Lung Dis. 2004. PMID: 15527150
Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.
Espasa M, Salvadó M, Vicente E, Tudó G, Alcaide F, Coll P, Martin-Casabona N, Torra M, Fontanals D, González-Martín J. Espasa M, et al. Among authors: martin casabona n. J Clin Microbiol. 2012 Feb;50(2):488-91. doi: 10.1128/JCM.06432-11. Epub 2011 Nov 30. J Clin Microbiol. 2012. PMID: 22135258 Free PMC article.
Impaired fitness of Mycobacterium tuberculosis resistant isolates in a cell culture model of murine macrophages.
Rey-Jurado E, Tudó G, Borrell S, Alcaide F, Coll P, Español M, Martín-Casabona N, Mick V, Montemayor M, Moure R, Salvadó M, Vicente E, González-Martín J. Rey-Jurado E, et al. Among authors: martin casabona n. J Antimicrob Chemother. 2011 Oct;66(10):2277-80. doi: 10.1093/jac/dkr288. Epub 2011 Jul 25. J Antimicrob Chemother. 2011. PMID: 21791442
43 results